Jinghao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jinghao Wang has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
Nenghua Chen
Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China
3 shared publicationsQiaxin Xu
Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China
3 shared publicationsTingting Yu
Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China
3 shared publicationsXiujiao Deng
Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China
3 shared publicationsDongge Feng
Department of Pharmacy, The First Affiliated Hospital of Jinan University
2 shared publicationsHyo In Kim
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston 02215, USA
2 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17
Correction: Voriconazole-associated liver injury: clinical risk factor identification and predictive nomogram construction
- 27 March 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17
Open AccessCorrection: Voriconazole-associated liver injury: clinical risk factor identification and predictive nomogram construction
- Top Cited PapersOpen Access
- 4 February 2026
- Published by Elsevier in Metabolism
- Vol. 178, 156549
Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections
- 4 February 2026
- Published by Elsevier in Metabolism
- Vol. 178, 156549
Top Cited PapersOpen AccessRising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections
- Open Access
- 5 January 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1688711
Voriconazole-associated liver injury: clinical risk factor identification and predictive nomogram construction
Objective: Investigate the high risk factors contributed to voriconazole-induced liver injury and develop a predictive nomogram for voriconazole-induced liver injury risk, thereby optimizing the clinical medication safety. Methods: This observational study retrospectively analyzed the electronic health records of hospitalized patients who received voriconazole treatment or prophylaxis at a tertiary hospital. Patients who met the inclusion and exclusion criteria were enrolled between June 2020 and June 2024, and their general biological data were collected. The diagnosis and severity grading of voriconazole-associated liver injury were determined according to the diagnostic and treatment guidelines for drug-induced liver injury. Patients were categorized into liver injury and non-injury groups based on the results of post-treatment liver function tests. Associations between baseline characteristics and liver injury were analyzed using non-parametric and chi-squared tests. To avoid omitting potentially significant factors, variables demonstrating P ≤ 0.1 in univariate screening and retained through least absolute shrinkage and selection operator (LASSO) regression underwent multivariate logistic regression to identify independent predictors. The nomogram was developed and internally validated through receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis (DCA). Results: Among the 1,964 patients screened, 1,196 were excluded, leaving 768 patients included in the statistical analysis. Liver injury occurred in 95 patients, resulting in an incidence rate of 12.4%. Multivariable logistic regression analysis demonstrated that total cholesterol (TC) (OR = 1.893, P < 0.01), concomitant use of glucocorticoids (OR = 1.861, P = 0.041), ezetimibe (OR = 7.453, P = 0.047), and caspofungin (OR = 2.485, P = 0.032). Patients with TC levels exceeding 4.485 mmol/L exhibited a significantly elevated risk of liver injury. ROC analysis revealed an area under the curve (AUC) of 0.728 (95% CI: 0.66–0.797), with a sensitivity of 0.661 and specificity of 0.722. Internal validation indicated good discrimination and calibration, with predicted probabilities closely aligned with actual outcomes. The decision curve analysis suggested a substantial net clinical benefit. These findings were subsequently validated in a test cohort. Conclusion: Concomitant use of ezetimibe, caspofungin, glucocorticoids, and TC levels exceeding 4.485 mmol/L are independent risk factors for voriconazole-induced liver injury. The developed nomogram model offers clinically meaningful predictions for drug-induced liver injury risk, facilitating the optimization of voriconazole therapy safety.
- 5 January 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1688711
Open AccessVoriconazole-associated liver injury: clinical risk factor identification and predictive nomogram construction
Objective: Investigate the high risk factors contributed to voriconazole-induced liver injury and develop a predictive nomogram for voriconazole-induced liver injury risk, thereby optimizing the clinical medication safety. Methods: This observational study retrospectively analyzed the electronic health records of hospitalized patients who received voriconazole treatment or prophylaxis at a tertiary hospital. Patients who met the inclusion and exclusion criteria were enrolled between June 2020 and June 2024, and their general biological data were collected. The diagnosis and severity grading of voriconazole-associated liver injury were determined according to the diagnostic and treatment guidelines for drug-induced liver injury. Patients were categorized into liver injury and non-injury groups based on the results of post-treatment liver function tests. Associations between baseline characteristics and liver injury were analyzed using non-parametric and chi-squared tests. To avoid omitting potentially significant factors, variables demonstrating P ≤ 0.1 in univariate screening and retained through least absolute shrinkage and selection operator (LASSO) regression underwent multivariate logistic regression to identify independent predictors. The nomogram was developed and internally validated through receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis (DCA). Results: Among the 1,964 patients screened, 1,196 were excluded, leaving 768 patients included in the statistical analysis. Liver injury occurred in 95 patients, resulting in an incidence rate of 12.4%. Multivariable logistic regression analysis demonstrated that total cholesterol (TC) (OR = 1.893, P < 0.01), concomitant use of glucocorticoids (OR = 1.861, P = 0.041), ezetimibe (OR = 7.453, P = 0.047), and caspofungin (OR = 2.485, P = 0.032). Patients with TC levels exceeding 4.485 mmol/L exhibited a significantly elevated risk of liver injury. ROC analysis revealed an area under the curve (AUC) of 0.728 (95% CI: 0.66–0.797), with a sensitivity of 0.661 and specificity of 0.722. Internal validation indicated good discrimination and calibration, with predicted probabilities closely aligned with actual outcomes. The decision curve analysis suggested a substantial net clinical benefit. These findings were subsequently validated in a test cohort. Conclusion: Concomitant use of ezetimibe, caspofungin, glucocorticoids, and TC levels exceeding 4.485 mmol/L are independent risk factors for voriconazole-induced liver injury. The developed nomogram model offers clinically meaningful predictions for drug-induced liver injury risk, facilitating the optimization of voriconazole therapy safety.
- 1 December 2025
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 172 (12) , 127506
Fabrication of 3D Nitrogen-Doped Ordered Mesoporous Carbon-Modified Electrode for Highly Sensitive Detection of Acetaminophen in Urine Samples
Acetaminophen (AP) is an essential medication in clinical practice for treating fever and alleviating mild to moderate pain conditions, and monitoring its content is critical for safeguarding human health. However, there are challenges in efficiently and conveniently detecting the AP quantitatively. In this study, we synthesized three-dimensional nitrogen-doped ordered mesoporous carbon nanomaterials (3D-NOMC) and utilized to develop highly sensitive electrochemical sensors for detecting AP. Physico-chemical characterizations confirm that the synthesized 3D-NOMC possesses an ordered mesoporous nanostructure, which not only facilitates the mass transfer of AP on the electrode surface but also enhances interaction with active sites. Through systematic optimization of experimental parameters, the developed electrochemical sensor demonstrated excellent linearity across concentration range of 100 nM to 2 mM for AP, with a detection limit as low as 34.10 nM. Moreover, the fabricated sensor also shows outstanding selectivity and maintains stable analytical performance over a period of 40 days. For demonstration, the sensor was utilized to detect AP in urine samples and satisfactory recoveries (ranging from 98.58% to101.59%) were obtained. These results present a reliable electrochemical platform for the quantitative analysis of AP, significantly contributing to the precise and convenient monitoring of drug levels.
- 1 December 2025
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 172 (12) , 127506
Fabrication of 3D Nitrogen-Doped Ordered Mesoporous Carbon-Modified Electrode for Highly Sensitive Detection of Acetaminophen in Urine Samples
Acetaminophen (AP) is an essential medication in clinical practice for treating fever and alleviating mild to moderate pain conditions, and monitoring its content is critical for safeguarding human health. However, there are challenges in efficiently and conveniently detecting the AP quantitatively. In this study, we synthesized three-dimensional nitrogen-doped ordered mesoporous carbon nanomaterials (3D-NOMC) and utilized to develop highly sensitive electrochemical sensors for detecting AP. Physico-chemical characterizations confirm that the synthesized 3D-NOMC possesses an ordered mesoporous nanostructure, which not only facilitates the mass transfer of AP on the electrode surface but also enhances interaction with active sites. Through systematic optimization of experimental parameters, the developed electrochemical sensor demonstrated excellent linearity across concentration range of 100 nM to 2 mM for AP, with a detection limit as low as 34.10 nM. Moreover, the fabricated sensor also shows outstanding selectivity and maintains stable analytical performance over a period of 40 days. For demonstration, the sensor was utilized to detect AP in urine samples and satisfactory recoveries (ranging from 98.58% to101.59%) were obtained. These results present a reliable electrochemical platform for the quantitative analysis of AP, significantly contributing to the precise and convenient monitoring of drug levels.
- Open Access
- 27 November 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (12) , e71245
Dietary Index for Gut Microbiota and Leisure Time Physical Activity: The Potential Combined Protective Impact on Hypertension Risk
Emerging evidence highlights the gut microbiome's role in hypertension via microbial metabolites and endothelial dysfunction, while the Dietary Index for Gut Microbiota (DI‐GM) quantifies diet quality for microbiota health. In addition, leisure‐time physical activity (LTPA) also reduces blood pressure, but their combined impact on population‐level hypertension remains unclear. Therefore, this study explores the individual and joint effects of DI‐GM and LTPA on hypertension risk. To address this objective, we conducted a cross‐sectional study analysis of data from 27,643 adults in the National Health and Nutrition Examination Survey (NHANES 2007–2020). Excluding individuals with incomplete data, key variables included the DI‐GM and LTPA pattern (categorized by intensity, frequency, and regularity; regularly active defined as > 2 days/week). Weighted logistic regression models and restricted cubic splines (RCS) evaluated independent, joint, and non‐linear associations of DI‐GM and LTPA with hypertension, adjusting for covariates. The results showed that higher DI‐GM scores and greater weekly LTPA were inversely correlated with hypertension risk, exhibiting dose‐dependent patterns (16% lower odds for DI‐GM ≥ 6 vs. lowest groups; 16%–24% lower odds for LTPA (≥ 150 min/week) vs. lowest groups). RCS analysis showed a linear inverse dose–response relationship between DI‐GM and hypertension. The regularly active LTPA pattern (> 2 days/week) was linked to a 24% lower risk of hypertension (OR = 0.76, 95% CI = 0.69–0.84), and there was also a significant association observed for the weekend warrior LTPA pattern (1–2 days/week) (OR = 0.80, 95% CI = 0.64–0.99). Notably, joint analysis demonstrated that individuals with DI‐GM > 4 scores and LTPA ≥ 150 min/week or regularly LTPA pattern exhibited the lowest hypertension odds. In conclusion, both a high DI‐GM score (≥ 6 points) and sufficient LTPA (≥ 150 min/week) were independently associated with reduced odds of hypertension, with their combined effect amplifying protective benefits. Prospective studies are warranted to confirm temporality and causal pathways.
- 27 November 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (12) , e71245
Open AccessDietary Index for Gut Microbiota and Leisure Time Physical Activity: The Potential Combined Protective Impact on Hypertension Risk
Emerging evidence highlights the gut microbiome's role in hypertension via microbial metabolites and endothelial dysfunction, while the Dietary Index for Gut Microbiota (DI‐GM) quantifies diet quality for microbiota health. In addition, leisure‐time physical activity (LTPA) also reduces blood pressure, but their combined impact on population‐level hypertension remains unclear. Therefore, this study explores the individual and joint effects of DI‐GM and LTPA on hypertension risk. To address this objective, we conducted a cross‐sectional study analysis of data from 27,643 adults in the National Health and Nutrition Examination Survey (NHANES 2007–2020). Excluding individuals with incomplete data, key variables included the DI‐GM and LTPA pattern (categorized by intensity, frequency, and regularity; regularly active defined as > 2 days/week). Weighted logistic regression models and restricted cubic splines (RCS) evaluated independent, joint, and non‐linear associations of DI‐GM and LTPA with hypertension, adjusting for covariates. The results showed that higher DI‐GM scores and greater weekly LTPA were inversely correlated with hypertension risk, exhibiting dose‐dependent patterns (16% lower odds for DI‐GM ≥ 6 vs. lowest groups; 16%–24% lower odds for LTPA (≥ 150 min/week) vs. lowest groups). RCS analysis showed a linear inverse dose–response relationship between DI‐GM and hypertension. The regularly active LTPA pattern (> 2 days/week) was linked to a 24% lower risk of hypertension (OR = 0.76, 95% CI = 0.69–0.84), and there was also a significant association observed for the weekend warrior LTPA pattern (1–2 days/week) (OR = 0.80, 95% CI = 0.64–0.99). Notably, joint analysis demonstrated that individuals with DI‐GM > 4 scores and LTPA ≥ 150 min/week or regularly LTPA pattern exhibited the lowest hypertension odds. In conclusion, both a high DI‐GM score (≥ 6 points) and sufficient LTPA (≥ 150 min/week) were independently associated with reduced odds of hypertension, with their combined effect amplifying protective benefits. Prospective studies are warranted to confirm temporality and causal pathways.
- Open Access
- 30 August 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 249, 108320
Corrigendum to “Association of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study” [J. Respir. Med. 247 (2025) 108300]
- 30 August 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 249, 108320
Open AccessCorrigendum to “Association of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study” [J. Respir. Med. 247 (2025) 108300]
- Open Access
- 6 August 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 247, 108300
Association of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study
- 6 August 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 247, 108300
Open AccessAssociation of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study
- 18 March 2025
- Published by Elsevier in Life Sciences
- Vol. 370, 123570
MMP3 as a new target of Danshensu/tetramethylpyrazine derivative for attenuating cardiac fibrosis post-myocardial infarction
- 18 March 2025
- Published by Elsevier in Life Sciences
- Vol. 370, 123570
MMP3 as a new target of Danshensu/tetramethylpyrazine derivative for attenuating cardiac fibrosis post-myocardial infarction
- Open Access
- 1 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Genome-wide association analysis of hypertension and epigenetic aging reveals shared genetic architecture and identifies novel risk loci
Hypertension is a disease associated with epigenetic aging. However, the pathogenic mechanism underlying this relationship remains unclear. We aimed to characterize the shared genetic architecture of hypertension and epigenetic aging, and identify novel risk loci. Leveraging genome-wide association studies (GWAS) summary statistics of hypertension (129,909 cases and 354,689 controls) and four epigenetic clocks (N = 34,710), we investigated genetic architectures and genetic overlap using bivariate casual mixture model and conditional/conjunctional false discovery rate methods. Functional gene-sets pathway analyses were performed by functional mapping and gene annotation (FUMA) protocol. Hypertension was polygenic with 2.8 K trait-influencing genetic variants. We observed cross-trait genetic enrichment and genetic overlap between hypertension and all four measures of epigenetic aging. Further, we identified 32 distinct genomic loci jointly associated with hypertension and epigenetic aging. Notably, rs1849209 was shared between hypertension and three epigenetic clocks (HannumAge, IEAA, and PhenoAge). The shared loci exhibited a combination of concordant and discordant allelic effects. Functional gene-set analyses revealed significant enrichment in biological pathways related to sensory perception of smell and nervous system processes. We observed genetic overlaps with mixed effect directions between hypertension and all four epigenetic aging measures, and identified 32 shared distinct loci with mixed effect directions, 25 of which were novel for hypertension. Shared genes enriched in biological pathways related to olfaction.
- 1 August 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessGenome-wide association analysis of hypertension and epigenetic aging reveals shared genetic architecture and identifies novel risk loci
Hypertension is a disease associated with epigenetic aging. However, the pathogenic mechanism underlying this relationship remains unclear. We aimed to characterize the shared genetic architecture of hypertension and epigenetic aging, and identify novel risk loci. Leveraging genome-wide association studies (GWAS) summary statistics of hypertension (129,909 cases and 354,689 controls) and four epigenetic clocks (N = 34,710), we investigated genetic architectures and genetic overlap using bivariate casual mixture model and conditional/conjunctional false discovery rate methods. Functional gene-sets pathway analyses were performed by functional mapping and gene annotation (FUMA) protocol. Hypertension was polygenic with 2.8 K trait-influencing genetic variants. We observed cross-trait genetic enrichment and genetic overlap between hypertension and all four measures of epigenetic aging. Further, we identified 32 distinct genomic loci jointly associated with hypertension and epigenetic aging. Notably, rs1849209 was shared between hypertension and three epigenetic clocks (HannumAge, IEAA, and PhenoAge). The shared loci exhibited a combination of concordant and discordant allelic effects. Functional gene-set analyses revealed significant enrichment in biological pathways related to sensory perception of smell and nervous system processes. We observed genetic overlaps with mixed effect directions between hypertension and all four epigenetic aging measures, and identified 32 shared distinct loci with mixed effect directions, 25 of which were novel for hypertension. Shared genes enriched in biological pathways related to olfaction.